Author:
Armstrong David G,Boulton Andrew JM,Andros George,Attinger Christopher,Eisenbud David,Lavery Lawrence A,Lipsky Benjamin A,Mills Joseph L,Sibbald Gary,Smith Adrianne P,Wukich Dane,Margolis David J
Reference6 articles.
1. 1United States Food and Drug Administration (FDA). Guidance for Industry: chronic cutaneous ulcer and burn wounds-developing products for treatment. Washington, DC: Food and Drug Administration, 2006.
2. 2 Cardinal ME , Eisenbud DE , Phillips T , Armstrong DG , Harding KG. Nonlinear modeling of venous leg ulcer healing rates. Wound Repair & Regeneration. Diabetic Foot Conference (DFCon08) Los Angeles, 2008.
3. Surrogate end points for the treatment of diabetic neuropathic foot ulcers;Margolis;Diabetes Care,2003
4. Prediction of healing for postoperative diabetic foot wounds based on early wound area progression;Lavery;Diabetes Care,2008
5. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial;Sheehan;Diabetes Care,2003
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献